Dr Victoria Allgar

BSc (hons) PhD C.Stat CSi

Reader in Medical Statistics

Role at Hull York Medical School

Victoria Allgar is Reader in Medial Statistics at Hull York Medical School / Department of Health Sciences, University of York.  She sits within the Centre for Health and Population Sciences which is multidisciplinary, specialising in clinical trials, epidemiology, health economics, health services research, medicine and psychology.

Biography

Victoria Allgar joined Hull York Medical School in 2006. She joined the medical school as a Senior Lecturer in Medical Statistics and had previously worked at the Centre for Research in Primary Care, University of Leeds (2000-2006) as a Senior Research Fellow. Prior to this she worked as a Medical Statistician, Leeds Teaching Hospitals NHS Trust (1997-2000) and as a Research Associate, at the Department of Primary Health Care, University of Newcastle (1995-1997).

Research

The following highlights the successfully funded research from 2010 to date:

1. Diagnosis and Management of venous thromboembolism (VTE) in patients with advanced cancer: how do physicians decide? RfPB. £212,008. 2010

2. Early parenting interventions for families with young children showing severe attachment problems: an integrated evidence synthesis. HTA, £238,000, 2011

3. The NEON study: Does home oxygen therapy (HOT) in addition to standard care improve disease severity and symptoms in chronic heart failure? HTA. £1,208,901. 2011

4. Improving care for people with dementia: development and initial feasibility study for evaluation of life story work in dementia care. NIHR Health Services Research Programme, £430,648. 2011

5. Characteristics of unpaid carers for people at the end of their lives – a national survey and an in-depth exploration of the effects of age and socio-economic status on carer-experience. Marie Curie Cancer Care, £161,985. 2011

6. ASSSIST (Autism Spectrum Social Stories In Schools Trial), HTA. £530,937. 2012

7. A feasibility study and pilot trial of computerised cognitive behaviour therapy for depression in adolescents. RfPB. £247,936. 2012

8. Transforming community health services for children and young people who are ill: a quasi-experimental evaluation. NIHR Health Services and Delivery Research Programme. £405,130. 2012

9. Translation of the Strengths and Difficulties Questionnaire into British Sign Language. NIHR. £220,830. 2013

10. Understanding and reducing inequalities for people with cancer: a programme of work based in Yorkshire. Yorkshire Cancer Research. £899,947. 2013

11. Adaptation Validation And Translation of Autism Assessment - Research in Deaf children. MRC Developmental Pathway. £480,016. 2013

12. Home or care? Pathways and outcomes for maltreated children in a multi-ethnic cohort. ESRC, £1,330,160. 2014

13. Mapping and evaluating Specialist Autism Team service models. NIHR Health Services and Delivery Research Programme. £600,000. 2014

14. Morphine for the relief of breathlessness in stable chronic heart failure. British Heart Foundation. £655,288. 2014

15. Recognition of the need for a palliative approach to care for patients with heart failure, COPD or dementia compared to those with cancer using Clinical Practice Research Datalink Academy of Medical Sciences Starter Grant for Clinical Lecturers. £30,000. 2014

16. PLATONOX: Is efficacy of PLAtelet aggregation inhibition by Ticagrelor mediated P2Y12 blockade dependent upon endogenous Endothelial Nitric OXide? Astra Zeneca. £250,000. 2015

17. HIDDEN: Hospice Inpatient Deep vein thrombosis Detection study. Research for Patient Benefit (RfPB) Programme. £295,000. 2015

18. A study of patient acceptance of Two Week Wait urgent referral appointments for suspected cancer. Yorkshire Cancer Research. £173,023. 2015

19. Observing Fibrosis, Macular Atrophy and Sub retinal Highly Reflective Material – Before and After Intervention with Anti-VEGF Treatment: An extension to the EDNA Study. Novartis Pharmaceuticals UK Limited. 2016. £1,327,500. 2016

20. Characterizing hip morphology for patient stratification. White Rose Collaboration Fund. £10,795. 2016

21. Does the use of a clinician-rated needs assessment tool for people with interstitial lung disease reduce the level of unmet patient and carer need? A feasibility study. Marie Curie. £118,682, 2016

22. Reducing inequalities in care for people with cancer and palliative care needs: a programme of work for cancer patients and caregivers in the community based in Yorkshire. Yorkshire Cancer Research. £1,469,537. 2016

23. Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research (Application for release of University of Hull Endowment). Yorkshire Cancer Research. £4,945,546. 2017

24. PEOPLE-HULL: Primary care and community Engagement to Optimise time to Presentation with Lung cancEr symptoms in HULL. Yorkshire Cancer Research. £712,501. 2017

25. A Feasibility, Randomised Controlled Trial Of A Complex Breathlessness Intervention In Idiopathic Pulmonary Fibrosis. NIHR RfPB. £241,170. 2017

26. Autism Spectrum Social Stories In Schools Trial (ASSSIST 2): A randomised controlled trial and economic evaluation of a Social Stories intervention to address the social and emotional health of children with ASD in mainstream primary schools. NIHR HTA. £586,411. 2018

27. Breathlessness RElief AT HomE (BREATHE): A feasibility cluster randomised controlled trial (cRCT) to test if a definitive cRCT is possible to evaluate the effectiveness and cost-effectiveness of a paramedic-administered breathlessness crisis intervention for people with acute-on-chronic breathlessness compared with usual care. NIHR RfPB. £248,603. 2018

Teaching

Academic Lead for Phase 1 assessment( 2017-Date). I deliver Hull York Medical School plenary lectures to Year 1 MBBS students on statistical methods (2007-Date). I lead a Scholarship and Special Interest Programme (SSIP)to year 1 and year 2 students. I undertake marking of end of year exam papers and dissertations for Hull York Medical School and Health Sciences.I provide pastoral support to students and lead a mentoring programme for academic and professional support staff.

Publications

View Victoria's publications on the PURE research database on the University of York website.

Postgraduate research supervision

I sit on and chair numerous Thesis Advisory Panels (TAPs) for postgraduate students (MD and PhD) in Hull York Medical School. I am a formal named supervisor for students within Hull York Medical School and Health Sciences.

External roles

I am a member of funding panels responsible for awarding research grants:

  • Charitable Trust Scientific Panel for the Chartered Society of Physiotherapy (Sept 2002 – 2018).
  • Grant Review Panel for the Multiple Sclerosis Society (July 2014 – Date).
  • Health Services Research Initiative Panel for Arthritis UK (April 2016 – 2017) and then Treatment Subcommittee Versus Arthritis (formally Arthritis UK) (November 2017 – Date).

The following are my current membership details of external Trial Steering Committees (TSCs):

  • The ECASS Study (Evaluation of a Computer Aid for assessing Stomach Symptoms). Lead University of Durham, Cambridge and Bangor.
  • PROVE: Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture (PROVE) – University of Oxford.
  • Trial of Proton Pump Inhibitors in Throat Symptoms: TOPPITS, University of Newcastle upon Tyne.
  • FIDELITY: Feasibility of Internet DELivery of Intensive TherapY for children with motor speech disorders and cerebral palsy. University of Newcastle upon Tyne.
  • HART: Hughes Abdominal Repair Trial, Cardiff University6. Awareness and Beliefs About Cancer: Phase 3, Cardiff University.
Honours and awards

Royal Statistical Society: Awarded Chartered Statistician in 1999 (C.Stat) and Science Council Awarded Chartered Scientist status (CSi) in 2012. Successful revalidation in December 2017 based on submitted evidence of continuing professional development activities).